The mental healthcare system is in desperate need of innovation.

By combining the ubiquity of digital tools with emerging technologies, we stand to be able to bring patients the care they need, wherever they need it.

An atai Life Sciences company

IntroSpect Digital Therapeutics is an initiative designed to extend the life changing potential of psychedelics-assisted psychotherapy to patients in a scalable and equitable way.

Using the flexibility and power of digital technology allows us to be more capable than ever of meeting patients on their own terms. By using a variety of digital biomarkers, we stand to make treatments increasingly refined, effective, and – most importantly for mental healthcare – individualized.’

- David Keene

, CEO, Introspect Digital Therapeutics

Our Team

The Introspect Team

David
Keene

VP, Digital Therapeutics

Jon
Sirota

Senior Manager, DIGITAL & COMMERCIAL

Srinivas Rao,
M.D., Ph.D.

Co-founder & Chief Scientific Officer

Florian
Brand

Co-founder & Chief Executive Officer

Roman
Dahl

VP, Strategy & Innovation

News

Contact

We'd love to hear from you.

Better mental healthcare is possible. Contact us to learn more about our mission and work.

[email protected]

 

Support

For clinical help, always contact your doctor directly.

Contact us with any technical issues you may be experiencing.

[email protected]
(619) 363 2359

Follow us on socials







    This site is protected by reCAPTCHA and the Google
    Privacy Policy and
    Terms of Service apply.

    JOIN THE ATAI #INSIGHTNETWORK

    Want to learn more?
    Sign up for weekly updates.

    Email
    submit